In a significant move towards enhanced public health safety, the US Environmental Protection Agency (EPA) has proposed the inclusion of microplastics and pharmaceuticals in its list of contaminants that threaten drinking water. This initiative, made public on 2 April, marks a critical milestone in the ongoing battle against plastic pollution and pharmaceutical contamination, addressing growing concerns among American citizens regarding the quality of their tap water.
A Historic Proposal
The announcement was made by EPA Administrator Lee Zeldin during a press conference at the agency’s headquarters. Zeldin stated that this proposal reflects the agency’s responsive approach to the concerns voiced by the American public regarding the presence of harmful substances in their drinking water. This action is seen as an early victory for Robert F. Kennedy Jr.’s Maha movement, which has actively campaigned for stricter regulations on environmental pollutants.
For the first time, microplastics and pharmaceuticals will be considered in the EPA’s Contaminant Candidate List (CCL), which identifies substances not currently regulated under the Safe Drinking Water Act. The draft of the sixth version of the CCL will open for public comments for a period of 60 days, with finalization expected by mid-November.
Public Health Concerns
Zeldin emphasised the gravity of water safety for American families, stating, “I can’t think of an issue that hits closer to home for American families than the safety of their drinking water.” Research has increasingly highlighted the prevalence of microplastics not only in drinking water but also within the human body, being found in organs such as the heart, brain, and reproductive systems. While the long-term health implications remain under investigation, experts express growing concern about the potential risks posed by these contaminants.
Pharmaceuticals, which often enter the water supply through human excretion and are inadequately filtered out by conventional wastewater treatment systems, also raise alarms among public health advocates.
The Path Forward
The EPA’s CCL serves as a tool for prioritising research and regulatory measures, yet historically, the agency has rarely transitioned pollutants from the CCL into enforceable regulations for drinking water. Critics, including Erik Olson, a senior attorney at the Natural Resources Defense Council, warn that the process may lead to inaction. “It’s the beginning of a very long process that routinely ends in nothing,” Olson remarked.
In contrast, environmental advocates view the proposal as a promising starting point. Judith Enck, former EPA regional administrator and current head of Beyond Plastics, stated that this inclusion could pave the way for future regulations on microplastics in public water supplies.
Dr Philip Landrigan, director of the Global Observatory on Planetary Health at Boston College, cautioned that while the EPA’s proposal is a step in the right direction, it must be complemented by broader measures to curtail plastic production to truly mitigate the issue of plastic pollution.
Industry Reactions and Future Initiatives
The American Chemistry Council, representing industry interests, expressed support for monitoring microplastics in drinking water, provided that the approach is standardised across the nation. Meanwhile, the Maha movement, led by Kennedy, continues to seek a comprehensive agenda from the EPA that includes monitoring microplastics, setting exposure limits, and instituting a moratorium on new plastic production facilities.
Kennedy recently announced a $144 million initiative, Systematic Targeting of Microplastics (STOMP), aimed at developing methodologies for detecting and understanding microplastics’ movement within the human body. He stated, “We can’t treat what we cannot measure. We cannot regulate what we don’t understand.” His commitment to addressing microplastic contamination is a core part of his independent presidential campaign for 2024.
The Bigger Picture
The Safe Drinking Water Act mandates the EPA to publish the CCL every five years, compelling the agency to evaluate at least five contaminants for potential regulation. Historically, however, the agency has frequently deemed such action unnecessary, reflecting a broader trend of reducing environmental regulations. This latest proposal arrives during a time when the EPA is under scrutiny for its regulatory decisions, particularly those that pertain to “forever chemicals” and other pollutants.
The current draft CCL encompasses four contaminant groups—microplastics, pharmaceuticals, PFAS, and disinfection byproducts—alongside 75 chemicals and nine microbes that may be present in drinking water.
Why it Matters
The EPA’s proposal to designate microplastics and pharmaceuticals as contaminants is a crucial first step in addressing the pressing public health concerns surrounding drinking water safety. As awareness grows about the impacts of these pollutants, the agency’s actions could lay the foundation for more stringent regulations and monitoring practices that protect both human health and the environment. In an era where environmental integrity is paramount, the push for comprehensive action against plastic pollution and pharmaceutical contamination signals a necessary shift towards safeguarding future generations.
